Toward More Comprehensive Homologous Recombination Deficiency Assays in Ovarian Cancer, Part 1: Technical Considerations.

Quesada, Stanislas; Fabbro, Michel; Solassol, Jérôme

Quesada, Stanislas; Fabbro, Michel; Solassol, Jérôme.

Afiliação

Quesada S; Medical Oncology Department, Institut Régional du Cancer de Montpellier (ICM), 34298 Montpellier, France.
Fabbro M; Faculty of Medicine, University of Montpellier, 34090 Montpellier, France.
Solassol J; Medical Oncology Department, Institut Régional du Cancer de Montpellier (ICM), 34298 Montpellier, France.

Cancers (Basel) ; 14(5)2022 Feb 23.

Article em En | MEDLINE | ID: mdl-35267439

Palavras-chave

BRCA; HRD assays; PARP inhibitors; genomic scars; high-grade serous ovarian cancer; homologous recombination deficiency

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google